The Health and Healing Zone - Share experiences, ask for help or tell us about your journey

Therapist Web Design Service

Exclusive to The Zone

The Zone is offering our therapists a tailored website design package. Click the Design button for more information.

Latest Discussions

Click on above picture to enter the forum.

Search for a Therapist

Which therapy do you require:

(pick more then one with CTRL-click)

Where do you need this therapy:

(pick more then one with CTRL-click)

Search

Please use the Login button at the top of the page to add yourself to the therapist directory.

Courses / Events

Date

Locn

Event

Latest Health and "Oddly Enough" News

Game of cat and mouse blacks out Albania's capital

Friday 16 May 2008 08:56:48

TIRANA (Reuters) - A cat chasing a mouse in Tirana's main power station caused a 72-hour blackout across parts of the Albanian capital, the electricity company said on Friday.

Oh deer! Man cops wrath of amorous stag

Friday 16 May 2008 08:56:48

SYDNEY (Reuters) - An Australian man was gored in the thigh on Friday by an amorous stag after entering a deer paddock in the middle of the breeding season.

Avastin improves brain cancer survival

Friday 16 May 2008 02:24:39

LOS ANGELES (Reuters) - Results from a mid-stage trial showed treatment with Genentech Inc's Avastin improved survival for patients with recurring brain cancer, the company said on Thursday.

Bone drugs seen helping fight cancer spread

Friday 16 May 2008 01:31:50

WASHINGTON (Reuters) - A drug prescribed to prevent fractures in breast cancer patients whose tumors have spread may actually help slow the cancer itself, U.S. researchers reported on Thursday.

New scans prompt mastectomies for breast patients

Friday 16 May 2008 01:30:08

WASHINGTON (Reuters) - Breast cancer patients who get newer scans called magnetic resonance imaging are more likely to opt for mastectomies, U.S. researchers reported on Thursday.

Lung cancer patients live longer with Alimta: study

Friday 16 May 2008 01:28:30

WASHINGTON (Reuters) - Lung cancer patients who took Eli Lilly and Co's Alimta after finishing their normal course of chemotherapy lived 40 percent longer without any tumor progression than patients who took a placebo, researchers reported on Thursday.